Pharmaceutical firm Biocon is expected to report a growth of 18% quarter-on-quarter in profit after tax of Rs 82 crore in the quarter ended September 2011. The company had reported net profit of Rs 70 crore in the previous quarter.
Revenues are seen going up by 9% to Rs 484 crore from Rs 443 crore quarter-on-quarter.
Earnings before interest, tax, depreciation and amortisation are likely to go up by 14% to Rs 139 crore from Rs 122 crore during the same period. Operating profit margin is expected to be at 28.8% as against 27.5%.
Second quarter expectations included numbers from BioPharma and CRAMS businesses.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
